SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001657494-16-000006
Filing Date
2016-08-15
Accepted
2016-08-15 16:34:25
Documents
2
Period of Report
2016-08-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1582
2 aurentzpoa.htm EX-24 3426
  Complete submission text file 0001657494-16-000006.txt   6660
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Issuer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EPIRUS BIOPHARMACEUTICALS, INC. 699 BOYLSTON STREET, 8TH FLOOR BOSTON MA 02116
Business Address C/O EPIRUS BIOPHARMACEUTICALS, INC. 699 BOYLSTON STREET, 8TH FLOOR BOSTON MA 02116 (617) 600-3497
Aurentz Vincent (Reporting) CIK: 0001657494 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-31161 | Film No.: 161833267